| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Immunovant, Inc. (IMVT) has 8 insiders with recent SEC Form 4 filings, including 2 buys and 8 sells. IMVT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.48M | $42.69M | - | |
| Other | 218.0K | $6.31M | - | |
| Other | 199.7K | $5.78M | - | |
| COO | 175.9K | $5.09M | - | |
| Other | 152.2K | $4.41M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 11, 2022 | Barnett Eva Renee58 | Chief Financial Officer | Sell | 12,500 | $9.44 | $118,000.00 | -4.4% | +101.5% | +294.0% | |
| Sep 30, 2022 | Pande Atul74 | Director | Buy | 15,000 | $5.60 | $84,000.00 | +300.0% | +212.0% | +588.0% | |
| Sep 29, 2022 | Torti Frank | Director | Buy | 20,000 | $5.81 | $116,200.00 | +5.4% | +221.6% | +613.6% | |
| Sep 28, 2022 | Butchko Julia G.46 | Chief Dev. &Tech. Officer | Sell | 535 | $4.67 | $2,498.45 | -0.1% | +258.2% | +730.7% | |
| Sep 28, 2022 | Salzmann Peter51 | Chief Executive Officer | Sell | 1,605 | $4.67 | $7,495.35 | -0.2% | +258.2% | +730.7% | |
| Aug 30, 2022 | Salzmann Peter51 | Chief Executive Officer | Sell | 1,644 | $5.83 | $9,584.52 | -0.2% | +158.7% | +331.1% | |
| Aug 30, 2022 | Butchko Julia G.46 | Chief Dev. &Tech. Officer | Sell | 548 | $5.83 | $3,194.84 | -0.1% | +158.7% | +331.1% | |
| Jul 27, 2022 | Butchko Julia G.46 | Chief Dev. &Tech. Officer | Sell | 510 | $4.27 | $2,177.70 | -0.2% | +142.5% | +412.5% | |
| Jul 27, 2022 | Salzmann Peter51 | Chief Executive Officer | Sell | 1,528 | $4.27 | $6,524.56 | -0.3% | +142.5% | +412.5% | |
| Jul 22, 2022 | MacIas William L.51 | Chief Medical Officer | Sell | 322 | $4.70 | $1,513.40 | -0.2% | +115.2% | +398.4% |